BIOLQ — November 26 Share News
0.000.00%
Last trade - 00:00FinancialsHighly SpeculativeMicro Cap
- $0.00m
- $12.94m
- $49.16m
Biolase Inc Expected To Post A Loss Of 64 Cents A Share: Earnings Preview
Biolase Inc Expected To Post A Loss Of 64 Cents A Share: Earnings Preview
Brief: BIOLASE Views Sonendo's Claims As "Meritless", Intends To Fight
U.S. STOCKS ON THE MOVE-Masimo, Icosavax, PayPal
U.S. STOCKS ON THE MOVE-Oatly, Yeti, OpGen
U.S. STOCKS ON THE MOVE-Gap, Levi Strauss, Novavax
U.S. STOCKS ON THE MOVE-Moderna, Party City, GoDaddy
Biolase up on higher prelim Q4 and full-year revenue
Brief: Biolase Inc Sees Q4 Revenue $14.0 Million To $14.4 Million
U.S. STOCKS ON THE MOVE-Cognizant, energy firms
Biolase falls on Nasdaq delisting notice
Brief: Biolase Inc Receives Notice Of Delisting From Nasdaq
Brief: Biolase Inc Announces Pricing Of About $9.75 Mln Underwritten Public Offering
Brief: Biolase Inc Enters Into The Tenth Amendment To Credit Agreement
Brief: Sonendo Unit Pipstek Files Patent Infringement Lawsuit Against Biolase
Brief: BIOLASE Files For Offering Of Units Each Consisting Of One Share Of Common Stock, Warrant To Purchase One Share Of Our Common Stock
Brief: Biolase Delivers 26% Revenue Growth Year Over Year In Third Quarter And Raises 2022 Full Year Revenue Guidance
Biolase Inc Reports Results For The Quarter Ended In September: Earnings Summary
Biolase Inc Expected To Post A Loss Of 84 Cents A Share: Earnings Preview